Hugo Morales‐Briceño

Hugo Morales‐Briceño

Auto-generated profile, based on publicly available information

Hugo Morales‐Briceño

Movement Disorders Unit, Neurology Department Westmead Hospital Westmead New South Wales Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
HMHugo Morales-Briceño
Hugo Morales-Briceño
ACAmin Cervantes-Arriaga
Amin Cervantes-Arriaga
MRMayela Rodríguez-Violante
Mayela Rodríguez-Violante
JCJuan Calleja
Juan Calleja
TCTeresa Corona
Teresa Corona
Underweight and malnutrition are well documented in Parkinson's disease (PD), while overweight has been less reported. We carried out a cross-sectional study including 177 healthy controls and 177 PD patients attending a tertiary care center. We recorded weight and height for all participants. A statistically significant difference was found in body mass index (BMI) between controls and PD patients (29.1±5.4 versus 27.2±4.7, p<0.001). In the PD Group, two patients were underweight, 32.7% were within normal range, 46.9% had overweight, and 19.2% were obese. Overweight and normal weight were more prevalent in the PD Group (p=<0.01 and <0.001, respectively) when compared to controls. In conclusion, overweight/obesity are common among patients with PD, while underweight is almost negligible.

1 July 2019 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
HMHugo Morales-Briceño
Hugo Morales-Briceño
AHAinhi D. Ha
Ainhi D. Ha
KLKevin London
Kevin London
DFDavid Farlow
David Farlow
FCFlorence C.F. Chang
Florence C.F. Chang
VFVictor S.C. Fung
Victor S.C. Fung

20 November 2018 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
BCBelinda Cruse
Belinda Cruse
HMHugo Morales-Briceño
Hugo Morales-Briceño
FCFlorence C F Chang
Florence C F Chang
NMNeil Mahant
Neil Mahant
AHAinhi D Ha
Ainhi D Ha
VFVictor S C Fung
Victor S C Fung
Levodopa-carbidopa intestinal gel (LCIG) is effective for the control of motor fluctuations in Parkinson’s disease (PD). The objective of this study is to report the reduction of dyskinesias after transitioning from 16 to 24-h/day LCIG infusion. From a cohort of 74 PD patients treated with LCIG for motor fluctuations, we identified 12 patients that were treated with 24-h per day infusion with the aim to control troublesome daytime dyskinesia. Clinical, demographic, dyskinesia rating scales were evaluated. Daytime dyskinesia was reduced in 75% (9/12) patients following treatment with 24-h therapy, including 7 who were compared with 16-h therapy and 2 that were transitioned from oral dopaminergic therapy to 24-h LCIG. Combining the data from all 12 subjects, troublesome dyskinesias were reduced during 24-h LCIG; UPDRS 4.1 (time spent with dyskinesias) mean change was −1.5 ± 0.75, p = 0.010 (Wilcoxon signed-rank test) and UPDRS 4.2 (functional impact of dyskinesias) mean change was −1.7 ± 0.90, p = 0.016, without changing their UPDRS part 3 “ON” scores (p = 0.138) or H&Y (p = 0.157). In 5 patients, improvement in dyskinesia occurred despite an overall increase in the total daily levodopa dose. None of the patients had worsening of dyskinesia after a median follow-up of 28 months. 24-h per day infusion of LCIG may be a useful strategy in the management of troublesome dyskinesias in PD patients with disabling dyskinesias resistant to attempts to optimise 16-hours per day therapy. We postulate that this may be due to a pharmacodynamic as opposed to pharmacokinetic mechanism.

1 February 2013 in Archives of Medical Research
Verified
Journal Article
Closed access
MRMayela Rodríguez-Violante
Mayela Rodríguez-Violante
ACAmin Cervantes-Arriaga
Amin Cervantes-Arriaga
TCTeresa Corona
Teresa Corona
DMDaniel Martínez-Ramírez
Daniel Martínez-Ramírez
HMHugo Morales-Briceño
Hugo Morales-Briceño
PMPablo Martínez-Martín
Pablo Martínez-Martín

28 November 2023 in Movement Disorders Clinical Practice
Verified
Journal Article
Closed access
LWLaura J. Williams
Laura J. Williams
SWSophie Waller
Sophie Waller
JQJessica Qiu
Jessica Qiu
EIEmily Innes
Emily Innes
NENoha Elserafy
Noha Elserafy
VFVictor S.C. Fung
Victor S.C. Fung

24 November 2021 in Movement Disorders Clinical Practice
Verified
Journal Article
Closed access
PDF file
SWSophie E. Waller
Sophie E. Waller
HMHugo Morales‐Briceño
Hugo Morales‐Briceño
LWLaura Williams
Laura Williams
SMShekeeb S. Mohammad
Shekeeb S. Mohammad
AFAvi Fellner
Avi Fellner
VFVictor S.C. Fung
Victor S.C. Fung